Skip to content
healthcare.dev
Get a free key

WEGOVY

NDC 0169-4915, semaglutide, injection, solution, from Novo Nordisk Pharmaceutical Industries, LP.

Product NDC
0169-4915
Status
Listed
Labeler
Novo Nordisk Pharmaceutical Industries, LP
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215256
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-4915 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SEMAGLUTIDE3.2 mg/mL

Pharmacologic classes

GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ee06186f-2aa3-4990-a760-757579d8f77b

Use it

Look up 0169-4915 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-4915 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-4915. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.